[ad_1]
MIT Tech Review reported that Amazon founder Jeff Bezos has invested in a new biotech startup dedicated to finding ways to reverse the aging process.
Altos Labs is a research company founded earlier this year that hires scientists with attractive offers of $ 1 million in annual salaries, according to the MIT Tech Review.
Citing people familiar with the matter, the site reported that Altos Labs had revealed that Jeff Bezos was among its investors.
Bezos resigned as CEO of Amazon in July. In a letter to employees in February, he said he would devote his time to philanthropic efforts and projects that reflect his passion, including his space exploration company Blue Origin.
Bezos has previously funded anti-aging research and in 2018 he invested in Unity Technologies, a biotech company that aims to make anti-aging treatments, Business Insider reported.
MIT Tech Review said Altos Labs will primarily focus on a technology called reprogramming, which works by adding protein to a cell that essentially allows it to return to a stem cell-like state.
Scientist Shinya Yamanaka won the 2012 Nobel Prize for demonstrating the technique in mice and has now joined Alto Labs as chairman of its scientific advisory board.
“While there are many hurdles to overcome, the potential is huge,” Yamanaka told MIT Tech Review in an email.
MIT Tech Review notes that Altos Labs plans to establish institutes in California, the UK, and Japan.
Source link
